Santilli A A, Scotese A C, Morris R L, Schiehser G A, Teller D M, Nielsen S T, Strike D P
Research Division, Wyeth Laboratories, Inc., Radnor, Pennsylvania 19087.
J Med Chem. 1988 Jul;31(7):1480-6. doi: 10.1021/jm00402a039.
The synthesis and gastric acid antisecretory properties of several N-substituted thieno[3,4-d]isothiazol-3-amine 1,1-dioxides and analogues are described. Two of the more potent compounds, N-[3-[3-(1-piperidinylmethyl)phenoxy]propyl]thieno[3,4-d] isothiazol-3-amine 1,1-dioxide (6a) and N-[4-[3-(1-piperidinylmethyl)phenoxy]propyl]thieno[3,4-d] isothiazol-3-amine 1,1-dioxide, showed greater potencies as H2-receptor antagonists (in vitro) than ranitidine. They also had potent gastric acid antisecretory activities in vivo, inhibiting basal acid secretion in the rat, histamine-stimulated acid secretion in the dog, and food-stimulated acid secretion in the dog. These were selected for further pharmacological evaluation.
描述了几种N-取代的噻吩并[3,4-d]异噻唑-3-胺1,1-二氧化物及其类似物的合成和胃酸分泌抑制特性。两种活性更强的化合物,N-[3-[3-(1-哌啶基甲基)苯氧基]丙基]噻吩并[3,4-d]异噻唑-3-胺1,1-二氧化物(6a)和N-[4-[3-(1-哌啶基甲基)苯氧基]丙基]噻吩并[3,4-d]异噻唑-3-胺1,1-二氧化物,作为H2受体拮抗剂(体外)显示出比雷尼替丁更强的效力。它们在体内也具有强大的胃酸分泌抑制活性,可抑制大鼠的基础胃酸分泌、犬的组胺刺激胃酸分泌以及犬的食物刺激胃酸分泌。这些被选用于进一步的药理学评估。